A prescription for change How the Medicare Act revises Hatch-Waxman to speed market entry of generic drugs
A
prescription for change
How the Medicare Act revises Hatch-Waxman to speed market entry of generic drugs
Greene
Stephanie M.
Greene, Stephanie M.
Dept. of Business Law, Carroll School of Management
Author
Author
text
article
2005 2005 monographic
2005
2005
monographic
English eng
English
eng
electronic application/pdf digitized other analog
electronic
application/pdf
digitized other analog
The author reviews the pharmaceutical industry’s patenting process as it has been impacted by the Hatch-Waxman and Medicare legislation which expedite review and approval for generic follow-on drugs. The pharmaceutical industry’s business model of investment in research and development to create and patent innovations in drug therapies, has proven to be successful. Evidence suggests however, that the industry overreached in prolonging the life of its drug patents to the detriment of competitors and consumers. The legislative efforts which substantially increased the availability of generics caused pharmaceutical companies to reconsider their processes as well. This article considers ways to incent innovation while benefiting the public from these innovations. The complex regulatory scheme highlights the fact that unexpected problems occur which may necessitate further legislative amendments that will provide guidance for courts where there is need for further interpretation.
Version of record.
Electronic reproduction. Chestnut Hill, Mass. : University Libraries, Boston College, 2009.
The Journal of Corporation Law 0360-795X 30 2 309 355 pp. 309-355 Winter 2005
The Journal of Corporation Law
The
Journal of Corporation Law
0360-795X
30 2 309 355 pp. 309-355 Winter 2005
30
30
2
2
309 355 pp. 309-355
309
355
pp. 309-355
Winter 2005
Use of this resource is governed by the terms and conditions of the Creative Commons "Attribution-Noncommercial-No Derivative Works 3.0 United States" (http://creativecommons.org/licenses/by-nc-nd/3.0/us/)
Business Law JCL-v30-Greene-p309.pdf JCL-v30-Greene-permissions.pdf JCL-v30-cover-thumbnail.jpg
Business Law
JCL-v30-Greene-p309.pdf
JCL-v30-Greene-permissions.pdf
JCL-v30-cover-thumbnail.jpg
MChB English eng
MChB
English eng
English
eng